Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029629
Abstract: Rationale: Dacomitinib-induced liver injury is often manifested by mild elevations of transaminases and bilirubin, and severe intrahepatic cholestasis caused by dacomitinib for simultaneous taking orally cytochrome P450 2D6 (CYP2D6) competitive substrates has been rarely reported.…
read more here.
Keywords:
cholestasis;
plasma exchange;
caused dacomitinib;
severe intrahepatic ... See more keywords